Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
BMC Public Health. 2008 Jul 31;8:267. doi: 10.1186/1471-2458-8-267.

Study protocol--metabolic syndrome, vitamin D and bone status in South Asian women living in Auckland, New Zealand: a randomised, placebo-controlled, double-blind vitamin D intervention.

Author information

  • 1Institute of Food, Nutrition and Human Health, Massey University, Palmerston North, New Zealand. p.r.vonhurst@massey.ac.nz

Abstract

BACKGROUND:

The identification of the vitamin D receptor in the endocrine pancreas suggests a role for vitamin D in insulin secretion. There is also some limited evidence that vitamin D influences insulin resistance, and thus the early stages of the development of type 2 diabetes.

METHODS:

Eighty-four women of South Asian origin, living in Auckland, New Zealand, were randomised to receive either a supplement (4000IU 25(OH)D3 per day) or a placebo for 6 months. At baseline, all participants were vitamin D deficient (serum 25(OH)D3 <50 nmol/L), insulin resistant (HOMA-IR > 1.93) and/or hyperinsulinaemic, hyperglycemic or had clinical signs of dislipidaemia. Changes in HOMA-IR, lipids, parathyroid hormone, calcium and bone markers were monitored at 3 months and 6 months.

DISCUSSION:

This randomised, controlled trial will be the first to investigate the effect of vitamin D supplementation on insulin resistance in non-diabetic subjects. It will subsequently contribute to the growing body of evidence about the role of vitamin D in metabolic syndrome. Registered clinical.

TRIAL REGISTRATION:

Registered clinical trial--Registration No. ACTRN12607000642482.

PMID:
18667086
[PubMed - indexed for MEDLINE]
PMCID:
PMC2518926
Free PMC Article

Images from this publication.See all images (1)Free text

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for BioMed Central Icon for PubMed Central
    Loading ...
    Write to the Help Desk